Malondialdehyde serum concentration in type 1 diabetic with and without retinopaty

Documenta Ophthalmologica

Volumn 93, Issue 3, 1997, Pages 223-229

  Losada, M ^a   Alio, J L ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

Author keywords

Diabetes; Lipid peroxidation; Malondialdehyde (MDA); Microangiopathy; Retinopathy

Indexed keywords

HEMOGLOBIN; MALONALDEHYDE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIABETIC RETINOPATHY; FEMALE; GLYCOSYLATION; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; PATHOPHYSIOLOGY;

EID: 0030319454     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02569062     Document Type: Article

References (19)

1. Wolff SP. The potential role of oxidative stress in diabetes and its complications: novel implications for theory and theraphy. In: Crabbe MJC, ed. Diabetic Complications: Scientific and Clinical Aspects. London: Churchill Livingstone 1987: 167-221.
2. Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacob HS. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. J Clin Invest 1978; 61: 1161-1167.
3. Lunec J, Malloran SP, White AC, Dormand TL. Free radical oxidation (peroxidation) in serum and synovial fluid in rhematoid arthritis. J Rheumatol 1981; 8(2): 233-245.
4. Warso MA, Lands WEM. Lipid peroxidation in relation to prostacyclin and tromboxane physiology and pathophysiology. Br Med Bull 1983; 39(3): 277-280.
5. Yagi K. A simple flurometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212-216.
6. Mallia A, Hermanson GT, Krohn RI. Preparation and use of a boronic acid support for separation and quantification of glycosylated haemoglobins. Anal Lett 1981; 14: 649-661.
7. Siu GM, Draper HH. Metabolism of malonaldehyde in vivo and in vitro. Lipids 182; 17: 349-355.
8. Sato Y, Hotta N, Sakamoto N, Matsouka S, Ohishi N, Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem Med 1987; 21: 104-107.
9. Abdella N, Awadi F, Salman A, Armstrong D. Thiobarbituric acid test as a measure of lipid peroxidation in arab patients with NIDDM. Diabetes Res 1990; 15: 173-177.
10. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetics patients. Biochem Med 181; 15: 373-378.
11. Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clinica Chimica Acta 1993; 14: 227-234.
12. Gutteridge JMC. Superoxide dismutase and free radicals in clinical chemistry. Ann Clin Biochem 1976; 13: 393-398.
13. Jenning PE, McLaren M, Scott NA, Saniabadi AR, Belch JJF. The relationship of oxidative stress to thrombotic tendency in type I diabetic patients with retinapathy. Diabetic Med 1991; 8: 860-865.
14. Monnier VM, Vishwanath V, Frank KE, Elmets CA Dauchot P, Kohn RR. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986; 314: 403-408.
15. Altomare E, Vendemiale G, Chicco D, Proacacci V, Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabete & Metabolisme 1992; 18: 264-271.
16. Stringer MD, Görog PG, Freeman A, Kakkar W. Lipid peroxides and atherosclerosis. Br Med J 1989; 298: 282-284.
17. Katoh K. Possible relevance of lipid peroxidation and thromboxane production to the initiation and or evolution of microangiopathy an non-hyperlipidemic type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 1992; 18: 89-98.
18. Arshad MAQ, Mooradian MD. Increased serum conjugated dienes in elderly diabetics patients. J Am Geriatrics Society. 1991; 39: 575-580.
19. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991; 40: 405-412.